D. Anderson & Company Among Top Women-Owned Businesses in Dallas
D. Anderson & Company (DAC), a global leader in patient recruitment and retention, has been named one of the 50 Largest Women-Owned Businesses in Dallas-Ft. Worth for 2008.
November 10, 2008 D. Anderson & Company (DAC), a global leader in patient recruitment and retention, has been named one of the 50 Largest Women-Owned Businesses in Dallas-Ft. Worth for 2008. The Dallas Business Journal bestows the coveted honor each year based on annual revenues and company size. Of 29,959 women-owned businesses in Dallas, according to the U.S. Census Bureau, DAC ranks 47th in terms of profits and personnel. President and CEO Diana Anderson, Ph.D., has positioned DAC as an international player boasting expertise in several therapeutic areas. The company began more than 18 years ago as a site management organization and evolved into one of the largest privately held patient recruitment and retention firms in the United States. DAC’s client list includes leading biotechnology and pharmaceutical companies worldwide. But it doesn’t end there. Urban hospitals, community clinics and private physicians call on DAC for strategic direction. The company reinforces its position as a thought leader by addressing delegates at key industry conferences worldwide and publishing authoritative books and articles. In 2007, DAC released “International Patient Recruitment Regulatory Guidelines, Customs and Practices,” which provides an expository view of legislation governing patient recruitment in 23 countries. This editorial endeavor elevated DAC’s profile on the international circuit. DAC is headquartered in Dallas with affiliate offices in Houston, Seattle and Windsor, U.K. For more information, visit www.dandersoncompany.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
